# Laser Photonics Corp: financial statements, quarterly

LASE · Nasdaq · CIK 1807887 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lase.md) · [Financials](/companies/lase/financials.md) · [Filings](/companies/lase/filings.md) · [Insiders](/companies/lase/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lase/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [1,303](/filings/0001493152-24-046462.md) | [995 d](/filings/0001641172-25-016194.md) | [743](/filings/0001641172-25-017657.md) | [623](/filings/0001641172-25-024367.md) | [717](/filings/0001493152-25-028857.md) | [1,332 d](/filings/0001493152-26-018110.md) | [2,290](/filings/0001493152-26-028310.md) | [2,599](/filings/0001493152-26-038459.md) | [919](/filings/0001493152-25-028857.md) | [2,533 d](/filings/0001493152-26-018110.md) | [916](/filings/0001493152-26-028310.md) | [1,806](/filings/0001493152-26-038459.md) |
| Cost of revenue | $k | [333](/filings/0001493152-24-046462.md) | [155 d](/filings/0001641172-25-016194.md) | [357](/filings/0001641172-25-017657.md) | [308](/filings/0001641172-25-024367.md) | [107](/filings/0001493152-25-028857.md) | [2,228 d](/filings/0001493152-26-018110.md) | [1,390](/filings/0001493152-26-028310.md) | [1,496](/filings/0001493152-26-038459.md) | [1,104](/filings/0001493152-25-028857.md) | [3,676 d](/filings/0001493152-26-018110.md) | [1,304](/filings/0001493152-26-028310.md) | [1,654](/filings/0001493152-26-038459.md) |
| Gross profit | $k | [970](/filings/0001493152-24-046462.md) | [840 d](/filings/0001641172-25-016194.md) | [386](/filings/0001641172-25-017657.md) | [315](/filings/0001641172-25-024367.md) | [609](/filings/0001493152-25-028857.md) | [(896) d](/filings/0001493152-26-018110.md) | [900](/filings/0001493152-26-028310.md) | [1,103](/filings/0001493152-26-038459.md) | [(185)](/filings/0001493152-25-028857.md) | [(1,143) d](/filings/0001493152-26-018110.md) | [(388)](/filings/0001493152-26-028310.md) | [152](/filings/0001493152-26-038459.md) |
| Research and development | $k | [75.4](/filings/0001493152-24-046462.md) | [46.4 d](/filings/0001641172-25-016194.md) | [47.7](/filings/0001641172-25-017657.md) | [60.2](/filings/0001641172-25-024367.md) | [62.8](/filings/0001493152-25-028857.md) | [408 d](/filings/0001493152-26-018110.md) | [163](/filings/0001493152-26-028310.md) | [184](/filings/0001493152-26-038459.md) | [132](/filings/0001493152-25-028857.md) | [134 d](/filings/0001493152-26-018110.md) | [127](/filings/0001493152-26-028310.md) | [219](/filings/0001493152-26-038459.md) |
| Operating income | $k | [(891)](/filings/0001493152-24-046462.md) | [(521) d](/filings/0001641172-25-016194.md) | [(548)](/filings/0001641172-25-017657.md) | [(932)](/filings/0001641172-25-024367.md) | [(1,706)](/filings/0001493152-25-028857.md) | [(3,277) d](/filings/0001493152-26-018110.md) | [(1,573)](/filings/0001493152-26-028310.md) | [(963)](/filings/0001493152-26-038459.md) | [(3,217)](/filings/0001493152-25-028857.md) | [(7,540) d](/filings/0001493152-26-018110.md) | [(2,776)](/filings/0001493152-26-028310.md) | [(2,388)](/filings/0001493152-26-038459.md) |
| Interest expense | $k | [0.0](/filings/0001654954-23-014375.md) | [0.0 d](/filings/0001654954-24-004797.md) | not reported | not reported | not reported | not reported | [99.0](/filings/0001493152-26-028310.md) | [811](/filings/0001493152-26-038459.md) | not reported | not reported | [385](/filings/0001493152-26-028310.md) | [435](/filings/0001493152-26-038459.md) |
| Income tax | $k | [0.0](/filings/0001654954-23-014375.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(895)](/filings/0001493152-24-046462.md) | [(487) d](/filings/0001641172-25-016194.md) | [(546)](/filings/0001641172-25-017657.md) | [(934)](/filings/0001641172-25-024367.md) | [(1,625)](/filings/0001493152-25-028857.md) | [586 d](/filings/0001493152-26-018110.md) | [(1,681)](/filings/0001493152-26-028310.md) | [(1,774)](/filings/0001493152-26-038459.md) | [(4,656)](/filings/0001493152-25-028857.md) | [(9,346) d](/filings/0001493152-26-018110.md) | [(2,946)](/filings/0001493152-26-028310.md) | [(3,278)](/filings/0001493152-26-038459.md) |
| Diluted EPS | $ per share | [(0.11)](/filings/0001493152-24-046462.md) | not reported | [(0.06)](/filings/0001641172-25-017657.md) | [(0.09)](/filings/0001641172-25-024367.md) | [(0.13)](/filings/0001493152-25-028857.md) | not reported | [(0.12)](/filings/0001641172-25-017657.md) | [(0.12)](/filings/0001493152-26-038459.md) | [(0.27)](/filings/0001493152-25-028857.md) | not reported | not reported | [(0.08)](/filings/0001493152-26-038459.md) |
| Basic EPS | $ per share | [(0.11)](/filings/0001493152-24-046462.md) | not reported | [(0.06)](/filings/0001641172-25-017657.md) | [(0.09)](/filings/0001641172-25-024367.md) | [(0.13)](/filings/0001493152-25-028857.md) | not reported | [(0.12)](/filings/0001641172-25-017657.md) | [(0.12)](/filings/0001493152-26-038459.md) | [(0.27)](/filings/0001493152-25-028857.md) | not reported | not reported | [(0.08)](/filings/0001493152-26-038459.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [8.3](/filings/0001654954-23-014375.md) | [6.2](/filings/0001641172-25-016194.md) | [5.2](/filings/0001493152-24-020897.md) | [2.7](/filings/0001493152-24-037935.md) | [2.1](/filings/0001493152-24-046462.md) | [0.5](/filings/0001493152-25-028857.md) | [0.2](/filings/0001641172-25-017657.md) | [0.1](/filings/0001641172-25-024367.md) | [3.6](/filings/0001493152-25-028857.md) | [0.7](/filings/0001493152-26-038459.md) | [1.6](/filings/0001493152-26-028310.md) | [2.2](/filings/0001493152-26-038459.md) |
| Current assets | $m | [12.6](/filings/0001654954-23-014375.md) | [9.3](/filings/0001641172-25-016194.md) | [7.9](/filings/0001493152-24-020897.md) | [5.7](/filings/0001493152-24-037935.md) | [4.8](/filings/0001493152-24-046462.md) | [4.7](/filings/0001493152-26-018110.md) | [4.0](/filings/0001641172-25-017657.md) | [3.3](/filings/0001641172-25-024367.md) | [6.8](/filings/0001493152-25-028857.md) | [3.0](/filings/0001493152-26-038459.md) | [4.5](/filings/0001493152-26-028310.md) | [4.6](/filings/0001493152-26-038459.md) |
| Total assets | $m | [16.8](/filings/0001654954-23-014375.md) | [15.1](/filings/0001641172-25-016194.md) | [13.6](/filings/0001493152-24-020897.md) | [11.1](/filings/0001493152-24-037935.md) | [10.6](/filings/0001493152-24-046462.md) | [17.2](/filings/0001493152-26-018110.md) | [16.0](/filings/0001641172-25-017657.md) | [14.9](/filings/0001641172-25-024367.md) | [17.5](/filings/0001493152-25-028857.md) | [9.4](/filings/0001493152-26-038459.md) | [10.9](/filings/0001493152-26-028310.md) | [10.6](/filings/0001493152-26-038459.md) |
| Current liabilities | $m | [0.6](/filings/0001654954-23-014375.md) | [1.0](/filings/0001641172-25-016194.md) | [1.5](/filings/0001493152-24-020897.md) | [0.6](/filings/0001493152-24-037935.md) | [0.9](/filings/0001493152-24-046462.md) | [2.6](/filings/0001493152-26-018110.md) | [4.9](/filings/0001641172-25-017657.md) | [6.3](/filings/0001641172-25-024367.md) | [9.2](/filings/0001493152-25-028857.md) | [10.3](/filings/0001493152-26-038459.md) | [8.5](/filings/0001493152-26-028310.md) | [7.7](/filings/0001493152-26-038459.md) |
| Total liabilities | $m | [0.8](/filings/0001654954-23-014375.md) | [1.2](/filings/0001641172-25-016194.md) | [1.6](/filings/0001493152-24-020897.md) | [0.8](/filings/0001493152-24-037935.md) | [0.9](/filings/0001493152-24-046462.md) | [6.9](/filings/0001493152-26-018110.md) | [9.2](/filings/0001641172-25-017657.md) | [10.6](/filings/0001641172-25-024367.md) | [13.4](/filings/0001493152-25-028857.md) | [14.5](/filings/0001493152-26-038459.md) | [12.6](/filings/0001493152-26-028310.md) | [11.5](/filings/0001493152-26-038459.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [14.2](/filings/0001493152-24-046462.md) | [13.9](/filings/0001493152-26-018110.md) | [12.4](/filings/0001641172-25-017657.md) | [10.3](/filings/0001493152-25-028857.md) | [9.7](/filings/0001493152-25-028857.md) | [10.2](/filings/0001493152-26-038459.md) | [6.8](/filings/0001493152-26-028310.md) | [4.3](/filings/0001493152-26-038459.md) | [4.1](/filings/0001493152-25-028857.md) | [(5.0)](/filings/0001493152-26-038459.md) | [(1.7)](/filings/0001493152-26-028310.md) | [(0.9)](/filings/0001493152-26-038459.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(1,387) d](/filings/0001493152-24-046462.md) | [(1,996) d](/filings/0001641172-25-016194.md) | [(866)](/filings/0001641172-25-017657.md) | [(2,388) d](/filings/0001641172-25-024367.md) | [633 d](/filings/0001493152-25-028857.md) | [(6,517) d](/filings/0001493152-26-018110.md) | [(1,157)](/filings/0001493152-26-028310.md) | [(1,035) d](/filings/0001493152-26-038459.md) | [763 d](/filings/0001493152-25-028857.md) | [(4,961) d](/filings/0001493152-26-018110.md) | [(1,843)](/filings/0001493152-26-028310.md) | [(2,893) d](/filings/0001493152-26-038459.md) |
| Capital expenditure | $k | not reported | [(48.1) d](/filings/0001641172-25-016194.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2021 (2021-09-30) | Q3 FY2022 (2022-09-30) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [4.9](/filings/0001654954-22-015230.md) | [4.9](/filings/0001654954-22-015230.md) | [7.9](/filings/0001493152-24-037935.md) | [7.9](/filings/0001493152-24-046462.md) | [9.2](/filings/0001641172-25-017657.md) | [10.6](/filings/0001641172-25-024367.md) | [12.7](/filings/0001493152-25-028857.md) | [14.3](/filings/0001493152-26-028310.md) | [14.3](/filings/0001493152-26-038459.md) | [17.1](/filings/0001493152-25-028857.md) | [27.3](/filings/0001493152-26-028310.md) | [39.3](/filings/0001493152-26-038459.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 50,177,716 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-038459.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.